Biosens
Biosens is a deeptech life sciences company that operates in the research, development, production, and commercialization of portable laboratory tests, also known as rapid or point-of-care tests (POCT). They focus on transforming healthcare through innovative point-of-care diagnostics using advanced technologies such as biosensors, Graphene, Single-Domain Antibodies, CRISPR, and artificial intelligence. Their mission is to provide accessible advanced diagnostics that empower better health decisions and prioritize individual care, with a vision of care everywhere and diagnostics anytime.
Industries
Nr. of Employees
small (1-50)
Biosens
Av. Theodomiro Porto da Fonseca, 3101. Tecnosinos, Prédio 3. 93022-715, São Leopoldo, RS, Brasil.
Products
Portable point-of-care diagnostic tests
Portable rapid laboratory tests designed for point-of-care use that convert biological interactions into quantitative readouts for clinical decision support.
Portable point-of-care diagnostic tests
Portable rapid laboratory tests designed for point-of-care use that convert biological interactions into quantitative readouts for clinical decision support.
Services
End-to-end service from research and prototype development to production and commercialization of portable rapid diagnostic tests for decentralized healthcare settings.
End-to-end service from research and prototype development to production and commercialization of portable rapid diagnostic tests for decentralized healthcare settings.
Expertise Areas
- Point-of-care diagnostics
- Biosensor development
- Molecular diagnostics (CRISPR-based)
- Nanomaterials for sensors (graphene)
Key Technologies
- Biosensors
- Graphene-based sensor materials
- Single-domain antibody binders
- CRISPR-based detection methods
News & Updates
Biosens was selected as a Deep Tech Pioneer by Hello Tomorrow out of 4,600 applications from 120 countries.
Biosens was selected as a Deep Tech Pioneer by Hello Tomorrow out of 4,600 applications from 120 countries.